Author: OurCrowd

In the News: Coronavirus, industry reinvention & venture capital

The coronavirus crisis has created heightened awareness of healthcare challenges, which will cause more money to flow to what we have seen as traditionally underfunded areas – medtech, digital health, and research. Historically, venture investing right after major market downturns – such as after the Internet bubble burst in 2000-2002, and after the financial crisis of 2007-2009 — has proved lucrative because you’re buying at a discount. That’s a very good entry point for new venture investors. However this time, there is also a fundamental re-set and expansion of social and economic trends causing major disruption that will lead to further opportunities for those companies leading the change. Read my and others’ thoughts on “Recession, Reinvention and Opportunity” in this Israel21c piece. As organizations increasingly move their business processes online, threats to data and privacy have exploded. Join us for a webinar Thursday, May 14 at 9:00AM PDT, 12:00PM EDT, 7:00PM IDT on Cybersecurity & Insecurity: The New World of COVID-19 where experts from some of the leading cybersecurity companies around the world will explore the challenges for organizations protecting...

Read More

[ByondXR in CTech] הסטארט־אפ הישראלי ByondXR יקים חדרי תצוגה וירטואליים עבור דלתא גליל

החברה שעובדת עם חברות כמו קוקה קולה ו-Be תאפשר ליצרנית האופנה להציג פריטים בתלת מימד, לזרז את המכירות ללקוחות ולקניינים ולהפחית במשלוחים. מעבר להיבט הקיימות, המיזם יכול לחסוך בין חצי מיליון למיליון דולר בשנה Read more...

Read More

In the News: News from startups hard at work fighting COVID-19

We’re optimistic that the coronavirus vaccine being developed by MigVax can bring very, very good news to the world, as I told CBN. The company believes it can build off of the coronavirus vaccine they previously developed for poultry and adapt it for the human coronavirus. Hear more from me on the topic, on Israel’s Channel 13. Professor Ferid Murad of Stanford University won the 1998 Nobel Prize for discovering the role of nitric oxide in the cardiovascular system. He says the nitric oxide treatment for coronavirus by SaNOtize that proved 99% effective in killing coronavirus in lab tests at Utah State University and was approved for clinical trials by Health Canada “could be effective in treating infections, including COVID-19”. Read my thoughts here. Top Tech News Coronavirus and sports: OurCrowd portfolio company PlaySight is instrumental in bringing back tennis.  I told NoCamels, the crisis has accelerated digital tech trends at warp speed – Israeli VCs are cautiously optimistic about the future, despite pandemic.  “We’re getting closer than ever to COVID-19 vaccine clinical trials, and it is all thanks to...

Read More